Multidrug resistance: A role for cholesterol efflux pathways?

Trends in Biochemical Sciences

Volumn 25, Issue 11, 2000, Pages 530-534

  Liscovitch, Mordechai ^a   Lavie, Yaakov ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; CAVEOLIN; CELL SURFACE PROTEIN; CHOLESTEROL; CYTOTOXIC AGENT;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL MEMBRANE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DRUG TRANSPORT; HUMAN; MEMBRANE STRUCTURE; METABOLIC REGULATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0034327486     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(00)01668-6     Document Type: Review

References (57)

1. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture
2. Molecular dissection of the human multidrug resistance P-glycoprotein
3. Structure of the multidrug resistance P-glycoprotein
4. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein
5. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
6. Intracellular cholesterol transport
7. Intracellular cholesterol trafficking
8. Intracellular cholesterol transport
9. Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane
10. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
11. Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae
12. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
13. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
14. Dissecting the role of the Golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface
15. Lipids of the Golgi membrane
16. Functional rafts in cell membranes
17. Structure and origin of ordered lipid domains in biological membranes
18. VIP21/caveolin is a cholesterol-binding protein
19. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
20. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol
21. Intracellular cholesterol transport in synchronized human skin fibroblasts
22. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains
23. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages
24. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers
25. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol
26. Caveolae and sorting in the trans-Golgi network of epithelial cells
27. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
28. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae
29. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae
30. Reduction of caveolin and caveolae in oncogenically transformed cells
31. Elevated expression of caveolin is associated with prostate and breast cancer
32. RNA genetics of breast cancer: Maspin as paradigm
33. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
34. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
35. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
36. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
37. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
38. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells
39. Accumulation of glucosylceramides in multidrug-resistant cancer cells
40. Separation of 'glycosphingolipid signaling domain' from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling
41. Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines
42. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells
43. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries
44. Reverse transformation of multidrug-resistant cells
45. Multidrug resistance and malignancy in human osteosarcoma
46. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy
47. Structure and function of sphingolipid- and cholesterol-rich membrane rafts
48. Caveolins, liquid-ordered domains, and signal transduction
49. Cholesterol homeostasis. Modulation by amphiphiles
50. Role of multidrug resistance P-glycoprotein in cholesterol esterification
51. Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis
52. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol
53. Clinical drug resistance: The role of factors other than P-glycoprotein
54. Role of oncogenes in resistance and killing by cancer therapeutic agents
55. P-glycoprotein multidrug resistance and cancer
56. Export pumps for anionic conjugates encoded by MRP genes
57. The ABCs of cholesterol efflux